This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2004 Mar;28(3):223-4.

doi: 10.1016/j.leukres.2003.09.004.

Treatment of systemic mast cell disease: beyond interferon

PMID: 14687615
DOI: 10.1016/j.leukres.2003.09.004

Editorial

Treatment of systemic mast cell disease: beyond interferon

Ayalew Tefferi. Leuk Res. 2004 Mar.

. 2004 Mar;28(3):223-4.

doi: 10.1016/j.leukres.2003.09.004.

Author

PMID: 14687615
DOI: 10.1016/j.leukres.2003.09.004

No abstract available

PubMed Disclaimer

Comment on

Response to therapy with interferon alpha-2b and prednisolone in aggressive systemic mastocytosis: report of five cases and review of the literature.
Hauswirth AW, Simonitsch-Klupp I, Uffmann M, Koller E, Sperr WR, Lechner K, Valent P. Hauswirth AW, et al. Leuk Res. 2004 Mar;28(3):249-57. doi: 10.1016/s0145-2126(03)00259-5. Leuk Res. 2004. PMID: 14687620 Review.

Similar articles

FIP1L1-PDGFRalpha in hypereosinophilic syndrome and mastocytosis.
Gilliland G, Cools J, Stover EH, Wlodarska I, Marynen P. Gilliland G, et al. Hematol J. 2004;5 Suppl 3:S133-7. doi: 10.1038/sj.thj.6200439. Hematol J. 2004. PMID: 15190295 Review. No abstract available.
[Systemic mastocytosis].
Fain O, Stirnemann J, Eclache V, Barete S, Casassus P, Hermine O, Lorholary O. Fain O, et al. Presse Med. 2005 May 14;34(9):681-7. doi: 10.1016/s0755-4982(05)84013-8. Presse Med. 2005. PMID: 15988348 Review. French.
Imatinib mesylate in the treatment of systemic mastocytosis: a phase II trial.
Droogendijk HJ, Kluin-Nelemans HJ, van Doormaal JJ, Oranje AP, van de Loosdrecht AA, van Daele PL. Droogendijk HJ, et al. Cancer. 2006 Jul 15;107(2):345-51. doi: 10.1002/cncr.21996. Cancer. 2006. PMID: 16779792 Clinical Trial.
On being metachromatic: mystique and misunderstanding in mastocytosis.
Gotlib J. Gotlib J. Am J Hematol. 2009 Dec;84(12):779-81. doi: 10.1002/ajh.21575. Am J Hematol. 2009. PMID: 19899132 No abstract available.
Clinical, genetic, and therapeutic insights into systemic mast cell disease.
Tefferi A, Pardanani A. Tefferi A, et al. Curr Opin Hematol. 2004 Jan;11(1):58-64. doi: 10.1097/00062752-200401000-00009. Curr Opin Hematol. 2004. PMID: 14676628 Review.

See all similar articles

Cited by

Advanced mast cell disease: an Italian Hematological Multicenter experience.
Pagano L, Valentini CG, Caira M, Rondoni M, Van Lint MT, Candoni A, Allione B, Cattaneo C, Marbello L, Caramatti C, Pogliani EM, Iannitto E, Giona F, Ferrara F, Invernizzi R, Fanci R, Lunghi M, Fianchi L, Sanpaolo G, Stefani PM, Pulsoni A, Martinelli G, Leone G, Musto P. Pagano L, et al. Int J Hematol. 2008 Dec;88(5):483-488. doi: 10.1007/s12185-008-0166-4. Epub 2008 Nov 26. Int J Hematol. 2008. PMID: 19034614
Aggressive Systemic Mastocytosis in Association with Pure Red Cell Aplasia.
Karam D, Swiatkowski S, Ravipati M, Agrawal B. Karam D, et al. Case Rep Hematol. 2018 Jul 8;2018:6928571. doi: 10.1155/2018/6928571. eCollection 2018. Case Rep Hematol. 2018. PMID: 30069418 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science